Clinical Trial Update: Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease [Phase 2]

View source ↗

Summary

A randomized, placebo-controlled Phase 2 trial evaluating the efficacy and safety of PF-02545920 in Huntington's disease was completed, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• PF-02545920

Snippet

Sponsor: Pfizer | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17